Medicines (Pseudoephedrine) Amendment Regulations 2024
2024/4
Medicines (Pseudoephedrine) Amendment Regulations 2024
Cindy Kiro, Governor-General
Order in Council
At Wellington this 19th day of February 2024
Present:
Her Excellency the Governor-General in Council
These regulations are made under section 105 of the Medicines Act 1981—
(a)
on the advice and with the consent of the Executive Council; and
(b)
on the advice of the Minister of Health given after complying with that section.
Regulations
1 Title
These regulations are the Medicines (Pseudoephedrine) Amendment Regulations 2024.
2 Commencement
These regulations come into force on 21 March 2024.
3 Principal regulations
These regulations amend the Medicines Regulations 1984.
4 Schedule 1 amended
(1)
In Schedule 1, Part 1, item 1772, replace “Pseudoephedrine”
with “Pseudoephedrine; except when specified elsewhere in this schedule”
.
(2)
In Schedule 1, Part 2, after item 69, insert:
69A
Pseudoephedrine; in solid-dose cough or decongestant medicines containing not more than 60 milligrams per recommended dose and not more than 240 milligrams per recommended daily dose, in a pack size of 720 milligrams or less; in liquid-dose cough or decongestant medicines containing not more than 60 milligrams per recommended dose and not more than 240 milligrams per recommended daily dose, in a pack size of 800 milligrams or less
Nicola Purvis,
for Clerk of the Executive Council.
Explanatory note
This note is not part of the regulations but is intended to indicate their general effect.
These regulations, which come into force on 21 March 2024, amend the Medicines Regulations 1984 to change pseudoephedrine-based cold and flu medicines from prescription medicines to restricted medicines. This allows those medicines to be sold by a pharmacist without the customer needing a prescription. This aligns with changes to the Misuse of Drugs Act 1975 and the Misuse of Drugs Regulations 1977 to ease restrictions on the sale of cold and flu medicines containing pseudoephedrine.
Regulatory impact statement
The Ministry of Health produced a regulatory impact statement on 12 January 2024 to help inform the decisions taken by the Government relating to the contents of this instrument.
A copy of this regulatory impact statement can be found at—
Date of notification in Gazette: 22 February 2024.
These regulations are administered by the Ministry of Health.